v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Consolidated Statements of Operations and Comprehensive Loss    
Revenue $ 14,769,000 $ 12,348,000
Cost of goods sold 1,888,000 2,036,000
Gross profit 12,881,000 10,312,000
Operating expenses:    
Research and development 3,084,000 2,517,000
Selling, general and administrative 21,958,000 21,232,000
Total operating expenses 25,042,000 23,749,000
Loss from operations (12,161,000) (13,437,000)
Interest expense (1,551,000) (1,457,000)
Other income, net 593,000 1,123,000
Loss before income taxes (13,119,000) (13,771,000)
Benefit (provision) for income taxes (1,000) 5,000
Net loss (13,120,000) (13,766,000)
Comprehensive loss $ (13,120,000) $ (13,766,000)
Net loss per share, basic $ (0.5) $ (0.53)
Net loss per share, diluted $ (0.5) $ (0.53)
Weighted-average common shares used to compute net loss per share, basic 26,355,591 25,876,062
Weighted-average common shares used to compute net loss per share, diluted 26,355,591 25,876,062